| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |